What is HIND's health score?

Vyome Holdings, Inc (HIND) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is HIND's estimated fair value?

Based on our 5-year discounted cash flow model, Vyome Holdings, Inc's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is HIND undervalued or overvalued?

Our model currently rates HIND as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for HIND... Refresh in a moment for the full analysis.

Vyome Holdings, Inc (HIND)

Healthcare Inconclusive inconclusive weak

$2.16

Updated: 2026-06-06

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

53 Mixed

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

35 Weak

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.